FDA.reportPublic FDA data

Ingested gastric satiety device

Definition
An orally-administered device intended to facilitate weight loss and treat obesity through appetite control. It is designed to be swallowed before meals to form a viscous gel in the stomach and/or small intestine to increase distention, creating the sensation of fullness and causing the user to eat less. It may additionally slow down intestinal glucose absorption to improve glycaemic control. It typically includes natural or modified fibre which expands after absorbing water; it is available in tablet, capsule, and powder sachet forms. This is a single-use device.
GUDID devices
13
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00860517002603Plenity™ GELESIS, INC.MC04512020-03-09
00860517002665Plenity®GELESIS, INC.MC06832021-09-01
00860517002672Plenity®GELESIS, INC.MC06842021-09-01
08055162880078Plenity®GELESIS SRLMC08552026-01-14
10860517002631Plenity™ GELESIS, INC.MC04202020-05-06
20860517002638Plenity®GELESIS, INC.MC05602020-12-09
27290017914019EpitomeeEPITOMEE MEDICAL LTD6.62025-04-22
27290017914026EpitomeeEPITOMEE MEDICAL LTD6.62025-04-22
08055162880009Plenity®GELESIS SRLMC08552026-01-14
07290017914015EpitomeeEPITOMEE MEDICAL LTD6.62025-04-22
07290017914022EpitomeeEPITOMEE MEDICAL LTD6.62025-04-22
00860517002634Plenity™ GELESIS, INC.MC04202020-05-06
00860517002627Plenity™ GELESIS, INC.MC04512020-03-09